1100 Architect Named to Forbes Americas Top Architects 2025 List Unveils Bold BostonArea Project Rising Prices Reshape Consumer Spending on Live Music and Concerts This Summer Nike Stock Rebound Prospects Remain Uncertain Amid Ongoing Challenges Truth or Consequences Brewery Tour Featuring MillionBat Migration Draws Tourism Interest GigaIPOs Signal Structural Challenges in Public Equity Markets UK Exports to US Plunge 25 After Trumps Liberation Day TariffsTrade Deficit Emerges CTMX Q1 2026 Earnings NarrowerThanExpected Loss as Pipeline Progress Continues SAZ Q1 2026 Earnings EPS Deeply Misses Estimates as Net Investment Income Turns Negative LFST Q1 2026 Earnings Significant EPS Beat Fails to Lift Shares Chemed Corp CHE Q1 2026 Earnings EPS Beats Expectations Amid Strong Operational Performance MT Q1 2026 Earnings Modest EPS Beat Amid Revenue Uncertainty RDVT Q1 2026 Earnings Earnings Beat Estimates by Over 40 Stock Rises eXp World Holdings EXPI Holds Steady at 674 as Market Awaits Catalyst Gaia Inc GAIA Edges Higher Amid Modest Trading Activity Nuveen MultiMarket Income Fund JMM Holds Steady Near 578 as Trading Remains Subdued Dave Busters Shares Surge Over 6 as Stock Bounces from Support PLAY Centurion Acquisition Corp Warrant ALFUW Holds Steady at 014 as Trading Remains Rangebound Fastenal FAST Edges Higher Amid Steady Volume Testing Key Resistance Levels LQR House Inc YHC Edges Higher Amid Consolidation at 086 Support and Resistance Remain Key Replimune Group REPL Rises 28 Approaching Resistance at 497 LaFayette Acquisition Corp Rights LAFAR Holds Steady at 012 Amid Low Volatility PayPal Holdings PYPL Stabilizes Near 44 as Market Gauges Growth Outlook Ziff Davis ZD Edges Higher Amid Consolidation Near Key Support CD Rate Outlook for 2026 Potential Trends Amid Fed Policy Uncertainty EOLS Q1 2026 Earnings EPS Surprise of 6229 Drives Stock Higher Almonty Industries ALM Faces ProfitTaking After Recent Rally KOD Q1 2026 Earnings EPS Beat Despite No Revenue Stock Slips IRTC Q1 2026 Earnings Narrowing Losses Beat Expectations as Operating Discipline Drives Results TONX Q1 2026 Earnings EPS Surprise of 9655 Drives 62 Stock Gains Despite No Reported Revenue Dermata Therapeutics Q1 2026 Earnings NarrowerthanExpected Loss Supports Ongoing Clinical Development VSTS Q1 2026 Earnings Massive EPS Beat Drives Investor Scrutiny Amid Revenue Discretion BCDA Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline Bloomin Brands BLMN Q1 2026 Earnings EPS Surprise Lifts Shares Amid Strong Profitability